Abstract
Objectives Sleep disturbance is commonly reported by people with anxiety, depressive and personality disorders, but longitudinal studies exploring the interplay of the three with disturbed sleep have not previously been described.
Methods In this study sleep disturbance was examined among 89 patients initially presenting with anxiety or depressive disorders who provided follow-up at 12 and 30 year timepoints in The Nottingham Study of Neurotic Disorder. Multiple regression models were used to identify factors most predictive of poor sleep, and changes in sleep quality over time.
Results There were strong associations between poor sleep and contemporaneous severity of personality disorder and the presence of other mental disorders at 12 and 30 years follow-up, but not with disorder presence at other time points. Improvements in personality disorder were associated with improvements in sleep between time points, and attenuated the positive unadjusted effects of recovery from anxiety or depressive disorders to insignificance. Relapse into further episodes of mental disorder predicted poorer sleep, whereas worsening personality disorder was not predictive of significant changes when adjusting for other factors.
Conclusions This study demonstrates the complex interplay between anxiety, depressive and personality disorders and sleep disturbance over a long follow-up period. Future research might look to examine the relationship between personality disorder and disturbed sleep with interventional studies and by integrating personality trait research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Nottingham Study of Neurotic Disorder is supported by grants from the Mental Health Research Foundation (UK), Jessie Spencer Trust, Greater Manchester NHS Trust, Nicola Pigott Memorial Fund, and the Trent Regional Health Authority. JDK holds an Academic Clinical Fellowship funded by the National Institute for Health and Care Research (NIHR) UK. Infrastructure support for this research was provided by the NIHR Imperial Biomedical Research Centre. No dedicated funding was received for these analyses.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The original study was approved by the Nottingham Ethics Committee in 1983, and ethical approval to follow-up participants was granted by Northampton Research Ethics Committee (12/EM/0331).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes